16-21709955-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_144672.4(OTOA):c.1172C>T(p.Ser391Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000122 in 1,613,804 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144672.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152028Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251334Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135832
GnomAD4 exome AF: 0.000125 AC: 183AN: 1461776Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 80AN XY: 727202
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152028Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74256
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 22 Pathogenic:1Uncertain:1
- -
This variant occurred in compound heterozygosity with an OTOA frameshift variant in a patient with bilateral sensorineural hearing loss of onset <18 years, in a study of pediatric hearing loss conducted by the King Laboratory (Carlson RJ et al. JAMA-OtoHNS 2023). This patient’s family has no other history of hearing loss. This variant is a missense at a completely conserved site and is predicted to be damaging by multiple in-silico tools. As of January 2023, this variant has been reported to ClinVar as a variant of unknown significance and is found in 5 heterozygotes on gnomAD. Based on consistently predicted functional effect, compound heterozygosity with a loss-of-function variant, and goodness of fit of genotype to phenotype, we conclude that this variant is likely pathogenic. -
not provided Uncertain:2
Reported as a variant identified in a cohort of patients with congenital hearing loss; proband-specific clinical and variant information not provided; Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34335733) -
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 391 of the OTOA protein (p.Ser391Leu). This variant is present in population databases (rs727504599, gnomAD 0.005%). This missense change has been observed in individual(s) with clinical features of OTOA-related conditions (PMID: 36633841; internal data). ClinVar contains an entry for this variant (Variation ID: 179001). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The Ser391Leu variant in the OTOA gene has not been reported in individuals with hearing loss or in large population studies. Computational analyses (biochemica l amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest t hat the Ser391Leu variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, additional informatio n is needed to fully assess the clinical significance of the Ser391Leu variant. -
OTOA-related disorder Uncertain:1
The OTOA c.1172C>T variant is predicted to result in the amino acid substitution p.Ser391Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0050% of alleles in individuals of East Asian descent in gnomAD. This variant has been reported in the hemizygous state along with a full gene deletion in one other patient undergoing genetic testing for hearing loss at PreventionGenetics. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at